| PERIOD ENDING | 31-Dec-02 | 30-Sep-02 | 30-Jun-02 | 31-Mar-02 | | Total Revenue | 2,993 | 861 | 857 | 835 | | Cost of Revenue | 182 | 190 | 133 | 188 | | | Gross Profit | 2,811 | 671 | 725 | 646 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 163 | 131 | 373 | 211 | | Non Recurring | (615) |
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 3,262 | 540 | 351 | 436 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (2,929) | 447 | 2,966 | (1,274) | | Earnings Before Interest And Taxes | 750 | 987 | 351 | 436 | | Interest Expense | 528 | 528 | 523 | 514 | | Income Before Tax | 221 | 459 | (171) | (78) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (195) | 459 | 2,795 | (1,352) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
| (3,451) |
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (195) | 459 | (656) | (1,352) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($195) | $459 | ($656) | ($1,352) |
|
0.50% Nasdaq 0.00%
Income Statement
